Jpmorgan Chase & CO Titan Pharmaceuticals Inc Transaction History

Jpmorgan Chase & CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$0.26 - $0.48 $0 - $1	-3 Reduced 1.91%	154 $0
Q3 2023 Nov 14, 2023	BUY	$0.45 - $0.66 $43 - $63	96 Added 157.38%	157 $0
Q4 2022 Feb 13, 2023	BUY	$0.77 - $22.8 $46 - $1,390	61 New	61 $0
Q4 2021 Feb 10, 2022	SELL	$1.02 - $1.93 $8 - $15	-8 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$1.87 - $2.57 $14 - $20	8 New	8 $0

Ticker TTNP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,629,200
Market Cap $49.4M
Description
Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform. The company offers Probuphine implant for the maintenance treatment of opioid use disorder in clinically stable patients in Canada and the Euro...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.